Immunization in horses involves the administration of vaccines to stimulate an immune response, thereby providing protection against specific infectious diseases. Vaccines commonly used in equine medicine include those for equine influenza, tetanus, and West Nile virus. The process of immunization aims to prepare the horse's immune system to recognize and combat pathogens upon exposure. Vaccination schedules and protocols may vary based on factors such as age, health status, and regional disease prevalence. This page compiles peer-reviewed research studies and scholarly articles that explore the mechanisms, efficacy, and considerations of immunization practices in equine health.
Treffers HP, Heidelberger M, Freund J.1. Two horses were injected subcutaneously with alum-precipitated rabbit serum albumin. 2. The resulting antibody resembled diphtheria antitoxin and anti-egg albumin in the horse in giving a sharp zone of flocculation with antigen, in being water-soluble, in reactivity toward an anti-antibody rabbit serum, and in its electrophoretic properties. 3. The effect of continued immunization, and of variation in volume and temperature on the reactivity of the antibody are discussed. 4. Intravenous injection of the same antigen into horses did not give rise to detectable amounts of antibody of the same...
Findlay GM, Maccallum FO.(1) Among 3,100 persons immunized against yellow fever with virus and immune serum over a period of five years, 89 cases of jaundice have been traced.(2) The symptoms are those of a hepatitis and closely resemble those produced by common infective hepatic jaundice, cases of which have frequently been noted as occurring in the same areas.(3) The average period between the time of inoculation and the development of hepatitis is between two and three months.(4) Attention is directed to the occurrence of hepatitis in horses, usually two to three months after immunization against the viruses of hor...
Parker JT, McCoy MV.1. The serum of horses immunized with increasing doses of certain anaerobically produced autolysates of pneumococci contain potent neutralizing antibodies for the pneumotoxin. 2. The method for the in vitro titration of these horse antipneumotoxic serums is given.
Olitsky PK, Long PH.The virus of vesicular stomatitis is not readily killed by formalin. This chemical is one of a group which coagulates the proteins of the medium in which the virus is usually contained. It has already been found(7) that other reagents of the protein-coagulating group are not actively virucidal) and the effect of formalin in this instance is therefore characteristic of the group. The so called formalinized vaccines which give rise to immunity can be shown to have done so because of the presence of living virus. A single injection of such so called "vaccine," or of other material containing livi...
Wadsworth AB, Sickles GM.IT HAS BEEN SHOWN THAT THE PNEUMOCOCCUS MULTIPLYING IN THE TISSUES OF THE IMMUNIZED ANIMAL (HORSE) BECOMES ATTENUATED: loses, in varying degrees, its virulence, capacity of capsule formation, susceptibility to phagocytosis, and type specificity. The antigenic activity as an immunizing agent and the production of "soluble specific substance" are also altered. In some instances, the typical pneumococcus characteristics may be quickly restored by one or two passages through a susceptible animal (mouse). In others, virulence is not recovered and the organism remains atypical. Whether these changes...
Tatarov G, Dilovski M.An avirulent immunogenic virus strain mutant of the causative agent of rhinopneumonia was found to cause abortions and respiratory diseases in horses. The mutant was obtained with the use of a virulent strain that induced strongly manifested clinical symptoms of the disease, and was cultured in cell media containing 5-iodine-2-desoxiuridine as an antimetabolite, following a definite pattern. It was found that the mutant completely lost its virulence, however, it retained its immunogenicity. It likewise retained these newly acquired biologic properties with regard to its being stable and irreve...
Vianna AM, Santos AC, Cunha RC, de Souza Stori de Lara AP, Weege GB, Leivas Leite FP.Equine theileriosis is a severe equine disease caused by the protozoan Theileria equi, which is prevalent in tropical and subtropical areas. In this study, a recombinant equi merozoite antigen-2 (rEMA-2) of T. equi was used as an immunogen. Two groups of 10 mice each were divided into control and vaccinated groups. Sixty mares seronegative for theileriosis were divided in two groups, one vaccinated and another group as a control animal. Mice and mares of the vaccinated groups were inoculated with 150 μL of the vaccine containing 50 μg of rEMA-2 and 2 mL of the vaccine containing 200 ...
Velineni S, Timoney JF, Artiushin SC, Donahue JM, Steinman M.Foals of mares infected with Leptospira interrogans serovar Pomona type kennewicki (Lk) may be aborted/stillborn or delivered as healthy foals. Is fetal survival explained in part by the immune response of the fetus to Leptospira antigens? Objective: To describe an outbreak of Leptospira abortion in which infected mares delivered dead/sick or normal foals and determine specificities of antibody in a collection of 54 fetuses from similar outbreaks. Methods: Outbreak investigation in combination with a case-control study of a larger set of samples from aborted fetuses. Methods: Serology and poly...
Moore RM, Moulthrop JI, Sather GE, Holmes CL, Parker RL.Field studies were conducted in 1972 to determine the immunization status of equines along the Mexico, Arizona, and New Mexico borders. Interviews with horse owners were conducted along roads selected at random in the counties of Santa Cruz and Yuma, Ariz., and in Dona Ana County, N. Mex. At least 450 horse owners in each county were asked about the vaccination status of their animals, and information was taken on 1,260 animals. Blood specimens were obtained from every third equine, regardless of stated vaccination status, and tested for the presence of Venezuelan equine encephalitis (VEE), we...
Becker W.From 1981 until 1987 we investigated the more detailed circumstances regarding a prophylactic vaccination in altogether 37 stud farms with a history of virus abortion. In 23 cases, in which Prevaccinol and/or Resequin were used, it was found that the following of vaccination schedule and necessary immunization programmes respectively, had considerable imperfections. In seven cases prophylactic vaccinations were not carried out or corresponding questionnaires were not answered. The fact that in the present data no case of virus abortion was observed, when the mare was vaccinated according to th...
Roth TL, White KL, Thompson DL, Horohov DW.It has been proposed that PGE2 is an important immunosuppressant acting at the fetal-maternal interface during pregnancy. We have previously shown that horse conceptus-conditioned medium suppresses lymphocyte proliferation. This experiment was designed to determine if horse conceptus-derived immunosuppressive activity could be attributed to PGE2 production by the trophoblast tissue. Trophoblast tissue from 21-day-old conceptuses was cut into equal sections and cultured in the presence or absence of the prostaglandin inhibitor, indomethacin. Following culture, immunosuppressive activity and the...
Miranda ALS, Antunes BC, Minozzo JC, Lima SA, Botelho AFM, Campos MTG, Chávez-Olórtegui C, Soto-Blanco B.Antivenom production against venom relies on horses being immunized and bled for plasma harvest. One horse can partake in several cycles of antivenom production, which will require years of constant venom and adjuvant inoculation and bleeding. The actual impact on the health of horses that participate in several antivenom-producing cycles is unknown. Therefore, this study aimed to evaluate the general health status of horses that underwent at least six cycles of loxoscelic antivenom production. Seven crossbred horses that had partaken in six to eight complete antivenom-producing cycles were u...
Arifianto D, Esfandiari A, Wibawan IWT, Amrozi A, Maharani M, Darsono D, Setiadi H, Setiyono A.Horses used for antisera production are repeatedly hyperimmunized to produce high levels of specific antibodies. This prolonged process can lead to various health issues, including amyloidosis, which involves the accumulation of amyloid proteins in organs and tissues, potentially causing organ dysfunction and failure. These horses are often retired when they no longer produce adequate antibody levels. This study aimed to evaluate the impact of prolonged antisera production on the health of retired horses by examining their blood biochemistry and serum amyloid A (SAA) levels, which are indicato...
Brunner S, Fürst AE, Jackson MA.Dermal melanoma is a common neoplastic disease in horses, which occurs particularly in gray horses. There are various local and systemic therapeutic approaches to treat this skin tumor. Vaccination with human tyrosinase, ONCEPT ® vaccine, is a newer type of systemic melanoma therapy. In this study, the effectiveness of this ONCEPT ® vaccine was retrospectively examined in eight treated horses. In half of the horses (4) a positive change in tumor growth in the sense of retardation, stagnation and, in one of these horses, even reduction in the size of the melanomas was observed. Of the rem...
Rutberg AT, Grams KA.Wildlife managers and the public have expressed considerable interest in the use of contraception to help manage the populations of wild horses and burros (Equus caballus and E. asinus). Field testing has shown that two preparations of the porcine zona pellucida (PZP) vaccine, a simple emulsion (ZonaStat-H) and PZP-22 (which supplements ZonaStat-H with a controlled-release component) effectively prevent pregnancy in individual mares and can substantially reduce population foaling rates. To determine whether some PZP preparations might have secondary effects that harm treated mares or their foa...
Cohen ND, Hughes EV, Bayne C, Morris ERA, Bray JM, Landrock KK, Gonzales DM, Baker RM, Klein RL, Liu W, Legere RM, Wehmeyer SG, Bordin AI....Evaluate the immunogenicity of a vaccine targeting the S protein (Ssee) of Streptococcus equi subsp equi and determine antibody activity against Ssee in horses with strangles. Methods: The study was designed as a prospective experiment using 20 university-owned Quarter Horses and a cross-sectional serosurvey of 78 privately owned horses with strangles. Horses were immunized IM with 0 (n = 4), 200 (n = 8), or 400 (n = 8) μg of recombinant Ssee at weeks 0, 4, and 12. Serum and nasal secretions were collected at weeks 0, 4, 6, 12, 16, and 28 and tested by ELISA for immunoglobulin (Ig)-G against ...
Cohen ND, Hughes EV, Bayne C, Morris ERA, Bray JM, Landrock KK, Gonzales DM, Baker RM, Klein RL, Liu W, Legere RM, Wehmeyer SG, Bordin AI....Evaluate the immunogenicity of a vaccine targeting the S protein (Ssee) of Streptococcus equi subsp equi and determine antibody activity against Ssee in horses with strangles. Methods: The study was designed as a prospective experiment using 20 university-owned Quarter Horses and a cross-sectional serosurvey of 78 privately owned horses with strangles. Horses were immunized IM with 0 (n = 4), 200 (n = 8), or 400 (n = 8) μg of recombinant Ssee at weeks 0, 4, and 12. Serum and nasal secretions were collected at weeks 0, 4, 6, 12, 16, and 28 and tested by ELISA for immunoglobulin (Ig)-G against ...
Jacob O, Hause B, Peters-Smith K, Adam EN, Page AE, Floyd C, Tucker C, Eertink LG, Wang D, Li F.Equine sarcoids are the most identified skin tumors of horses, which are highly associated with bovine papillomavirus infection. Sarcoids can impair the use of the horse and are difficult to treat, resulting in significant economic losses and a welfare concern. There is no vaccine available to protect global equines from sarcoids. We aimed to determine the safety and protective antibody response in horses immunized with a recombinant baculovirus vector vaccine expressing the L1 protein of bovine papillomavirus type 1 (BPV1). A group of 10 clinically healthy, sarcoid-free horses were immunized ...
O'Kennedy MM, Reedy SE, Abolnik C, Khan A, Smith T, du Preez I, Olajide E, Daly J, Cullinane A, Chambers TM.Equine influenza (EI) is a highly contagious acute respiratory disease of wild and domesticated horses, donkeys, mules, and other Equidae. EI is caused by the Equine Influenza virus (EIV), is endemic in many countries and outbreaks still have a severe impact on the equine industry globally. Conventional EI vaccines are widely used, but a need exists for a platform that facilitates prompt manufacturing of a highly immunogenic, antigenically matched, updated vaccine product. Here we developed a plant-produced bivalent EI virus-like particle (VLP) vaccine candidate which lacks the viral genome an...
Rykala M, Jasiak M, Niedzwiedz A.Preventing the spread of infectious diseases in horses requires breaking the chain of infection through appropriate prophylaxis. In Poland, where the horse population reached 273,006 in 2023, vaccinations are voluntary and primarily the responsibility of horse owners, with mandatory influenza vaccinations limited to sport horses. This study aimed to evaluate the vaccination status of Polish horses against infectious diseases through a survey of 980 horse owners and an analysis of 123 horse passports from slaughterhouses. Survey participants represented all provinces, predominantly owning warmb...
Levasseur A, Paré J, Aubry P, Iwasawa S, Leung D, Arsenault J.Vaccination is the most efficient tool for preventing West Nile virus (WNV) disease in horses. The objectives of this retrospective study were to: i) estimate the provincial and national horse population in Canada; ii) estimate the annual vaccination coverage for WNV in each province; and iii) compare estimates of provincial annual vaccination coverage. Horse population data (2006-2023) and the number of vaccine doses sold in Canada (2016-2020) were obtained by province. Based on these data and expert consultations, the annual number of vaccine doses administered, and provincial horse populati...
da Silveira BP, Kahn SK, Legere RM, Bray JM, Cole-Pfeiffer HM, Golding MC, Cohen ND, Bordin AI.Using a horse foal model, we show that enteral immunization of newborn foals with Rhodococcus equi overcomes neonatal vaccination challenges by reprogramming innate immune responses, inducing R. equi-specific adaptive humoral and cell-mediated immune responses and protecting foals against experimental pneumonia challenge. Foals were immunized twice via gavage of R. equi (immunized group) or saline (control group) at ages 1 and 3 days. At age 28 days, all foals were challenged intrabronchially with R. equi. Post-challenge, all 5 immunized foals remained healthy, whereas 67% (4/6) of control foa...
Matté YA, Baldasso DZ, Rezende MA, Lui JFM, Seibel AC, Guizzo JA, Frandoloso R, Kreutz LC.Lawsonia intracellularis is an obligatory intracellular bacterium associated with equine proliferative enteropathy (EPE), which significantly impacts equine health. Despite its clinical relevance, epidemiological and diagnostic approaches for this infection in horses have remained underexplored. This study aimed to evaluate the humoral immune response in horses immunized with an experimental vaccine for L. intracellularis and to determine the occurrence of anti-L. intracellularis antibodies in horses from southern Brazil using the flow cytometry antibody test (FCAT). Unassigned: A total of 12 ...
Legere RM, Ott JA, Poveda C, Vanover D, Borba KER, Yeon Joo J, Martin CL, da Silveira BP, Bray JM, Landrock K, Wright GA, Blazier JC, Hillhouse AE....Inhalation of Rhodococcus equi causes severe pneumonia in humans and animals worldwide, most commonly affecting horse foals. The standard for preventing R. equi pneumonia in foals is transfusion of hyperimmune plasma, which is expensive and carries the risk of adverse effects. Our goal was to passively immunize foals against R. equi by nebulizing mRNA encoding an equine monoclonal antibody (mAb) against the virulence-associated protein A (VapA) directly into the lungs. VapA-specific memory B cells from an immunized horse were used to identify and select the sequence for an equine immunoglobuli...
Kutumbetov L, Myrzakhmetova B, Tussipova A, Zhapparova G, Tlenchiyeva T, Bissenbayeva K, Nurabayev S, Kerimbayev A.Equine rhinopneumonia, caused by equine herpesvirus types 1 and 4 (EHV-1 and EHV-4), continues to be a significant health and economic concern in the global equine industry, particularly in Kazakhstan. While vaccines targeting EHV-1 are available, there is currently no licensed monovalent vaccine for EHV-4, and existing formulations offer limited protection against this serotype. This study aimed to develop and evaluate a freeze-dried, live-attenuated EHV-4 vaccine with improved safety, stability, and immunogenicity. Methods: A field isolate of EHV-4 was attenuated through serial passaging in ...
Batterham R, Allen K, Dickson J, Warman S, Parkin T.To ensure veterinary students are prepared for clinical practice, curricula must provide opportunities for students to learn about the cases most frequently seen in practice. Currently, there is a gap in the literature with regard to the identification of common clinical topics encountered in equine primary care practice in the UK. This study aims to address this gap by utilizing text-mining techniques on electronic medical records (EMRs) to produce a ranked list of the most common clinical topics encountered in equine primary care in the UK. The study included 1,092,731 rows of data from 150,...
Golen GS, Erganiş O, Balevi A. is an important bacterial pathogen and causes severe chronic granulomatous pneumonia in foals below 6 months of age. It has also become an opportunistic and emerging pathogen in immunocompromised humans. Vaccination is the most cost-effective strategy for controlling and preventing this infection. Although several potential virulence genes and candidate immunogens have been identified over the years, no effective vaccine is currently available to prevent disease in horses. Recently, bacterial vector vaccines have been shown to be promising for In this study, the gene of was cloned into P...
Roncaglia-Pereira VA, Dumard CH, Monteiro-Machado M, Melo PA, Fonseca J, Meirelles L, Cunha-Ribeiro L, Souza P, da Silva JL, Castilho L....In this study, we aim to report the persistent presence of anti-SARS-CoV-2 immunoglobulins in pre-immunized mare offspring. Three mares from Vital Brazil Institute were pre-immunized with recombinant SARS-CoV-2 spike protein and became pregnant during this period. After parturition, the mares' serum and colostrum/milk and foal serum were collected over 6 weeks. Our results have shown high and persistent presence of IgG and neutralizing antibodies over the weeks not only in the mares' serum, as expected, but in mares' colostrum/milk and foal serum as well-what were very surprising. This peculia...
Acevedo-Jiménez GE, Morales-González C, Akbarin MM, Rodríguez-Murillo C, González-Fernández VD, Avila-De la Vega LM, García-Flores MM....Equine infectious anemia virus (EIAV) is a globally significant equine pathogen, and its control relies on effective serological surveillance. The agar gel immunodiffusion (AGID) test, the WOAH-prescribed method, has limitations in sensitivity. This study developed and validated an indirect ELISA using a synthetic peptide derived from a conserved region of the EIAV gp90 surface glycoprotein. The assay was evaluated using 773 horse sera from the Metropolitan Zone of the Valley of Mexico and compared to the AGID test. The gp90-EIAV ELISA demonstrated a sensitivity of 85.3 % and a specificity o...
von der Höden FJ, Stefansdottir SB, Torsteinsdottir S, Svansson V, Björnsson JM, Wagner B, Mahmuti D, Marti E, Jonsdottir S.Insect bite hypersensitivity (IBH) is a seasonal, IgE-mediated allergic dermatitis of horses caused by salivary gland proteins of biting midges ( spp.). Current management relies on relief of clinical signs and on physical protection. In a previous pilot study, healthy horses were fed transgenic barley expressing a allergen via a special spiral bit, which successfully induced allergen-specific antibody responses. Building on this concept, the present study aimed to evaluate a more practical feeding approach, delivering transgenic barley expressing the major allergen Cul o 2p in a feed-compat...
Bannai H, Kambayashi Y, Kume K, Takebe N, Endo Y, Kawanishi N, Nemoto M, Tsujimura K.The endemic situation of respiratory disease caused by equine herpesvirus type-1 (EHV-1) and type-4 (EHV-4) was investigated in a training facility for Thoroughbred yearlings in Japan. Vaccination typically starts in mid-September or early October-only after all yearlings have arrived-leaving those introduced earlier unprotected. To bridge this immunity gap, a revised vaccination program that started earlier was implemented. In 2021-2022 and 2022-2023, yearlings were allocated to three groups according to their introduction dates. Each group received a live EHV-1 vaccine (Equi N Tect ERP, Niss...
Whitlock F, Newton R, King S, Ionescu AM, Higgins S.With the geographical distribution of West Nile virus expanding, there is growing concern about the potential for an incursion to the UK. Here, Fleur Whitlock, Richard Newton, Simon King, Andra-Maria Ionescu and Sara Higgins provide a timely reminder of key aspects of the virus' biology.
Carey KJ, Smith I, Hartley CA, Bailey KE, McIntosh K, Broder CC, Gilkerson JR.Hendra virus (HeV) is a high consequence pathogen that causes severe respiratory and/or neurological disease in both horses and humans with high mortality. The equine vaccine, Equivac® HeV, is a recombinant soluble version of the G glycoprotein of HeV (HeV-sG) that elicits a potent HeV-neutralising antibody response in adult horses and also provides indirect protection for humans. Maternally derived HeV-G specific antibodies could interfere with subsequent foal vaccination, although other factors such as foal age and the suitability of vaccination protocols that have been optimised for adult ...
Conrad NL, Mazzoleni I, Abreu MC, Costa AV, Di Giácomo CP, Zorzi VSG, Leite FPL.Equine proliferative enteropathy (EPE), caused by Lawsonia intracellularis induces intestinal epithelial hyperplasia, resulting in malabsorption, weight loss, colic, and diarrhea. Despite its clinical and economic importance, no equine-specific vaccine is commercially available. Recombinant subunit vaccines are a safe and scalable alternative; however, their immunogenicity often requires improvement. Probiotic supplementation with Bacillus toyonensis may act as an immunomodulatory strategy to potentiate vaccine efficacy. This study aimed to evaluate the immunogenicity of a recombinant protein ...
Beniwal N, Lal B, Mithina S, Verma CK, Kumar S, Phagna V, Jakhar K, Sonar S, Gupta V, Singh R, Kumar N, Tan CW, Thachamvally R, Singha H, Murzello K....Rabies is a neglected tropical zoonotic disease caused by rabies-virus (RV) infection and is responsible for almost 60,000 annual deaths globally, largely affecting the socio-economically disadvantaged population. Although fatality is preventable by immunization either before or after exposure with therapeutic antibodies, the high cost of prophylaxis or treatment limits their accessibility for the affected population. However, due to the almost 100% fatality rate in symptomatic individuals, almost 29 million annual vaccinations are performed, imposing high financial burden. Human transmission ...
